UnitedHealth Group (NYSE:UNH) Price Target Cut to $400.00 by Analysts at Oppenheimer

UnitedHealth Group (NYSE:UNH) had its target price trimmed by Oppenheimer from $600.00 to $400.00 in a report released on Wednesday,Benzinga reports. The firm currently has an outperform rating on the healthcare conglomerate’s stock.

Several other research firms have also commented on UNH. Argus lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Monday, April 21st. Raymond James lowered shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research note on Wednesday. Bank of America cut shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $560.00 to $350.00 in a report on Wednesday. HSBC reissued a “hold” rating and issued a $490.00 price target on shares of UnitedHealth Group in a research report on Tuesday, April 22nd. Finally, Morgan Stanley reduced their price objective on UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating on the stock in a research note on Wednesday. Six analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average target price of $523.52.

UnitedHealth Group Price Performance

NYSE:UNH opened at $308.35 on Wednesday. The stock’s fifty day moving average is $478.83 and its two-hundred day moving average is $517.83. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $279.72 billion, a P/E ratio of 19.89, a P/E/G ratio of 1.37 and a beta of 0.56. UnitedHealth Group has a 52 week low of $284.25 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. During the same period last year, the business earned $6.91 EPS. Equities analysts expect that UnitedHealth Group will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 2.72%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 35.18%.

Institutional Investors Weigh In On UnitedHealth Group

Hedge funds have recently modified their holdings of the stock. Truvestments Capital LLC raised its position in UnitedHealth Group by 6.9% during the 1st quarter. Truvestments Capital LLC now owns 636 shares of the healthcare conglomerate’s stock worth $333,000 after buying an additional 41 shares during the last quarter. Wealth Preservation Advisors LLC purchased a new position in UnitedHealth Group during the first quarter worth about $218,000. B. Metzler seel. Sohn & Co. AG boosted its holdings in UnitedHealth Group by 10.1% in the 1st quarter. B. Metzler seel. Sohn & Co. AG now owns 443,840 shares of the healthcare conglomerate’s stock valued at $232,461,000 after purchasing an additional 40,759 shares in the last quarter. Delta Investment Management LLC raised its stake in shares of UnitedHealth Group by 1.3% during the 1st quarter. Delta Investment Management LLC now owns 6,782 shares of the healthcare conglomerate’s stock worth $3,552,000 after buying an additional 86 shares in the last quarter. Finally, Silvant Capital Management LLC boosted its stake in shares of UnitedHealth Group by 0.3% in the first quarter. Silvant Capital Management LLC now owns 61,442 shares of the healthcare conglomerate’s stock valued at $32,180,000 after buying an additional 179 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.